These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Neely LA; Rieger-Christ KM; Neto BS; Eroshkin A; Garver J; Patel S; Phung NA; McLaughlin S; Libertino JA; Whitney D; Summerhayes IC Urol Oncol; 2010; 28(1):39-48. PubMed ID: 18799331 [TBL] [Abstract][Full Text] [Related]
3. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479 [TBL] [Abstract][Full Text] [Related]
4. Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile. Dip N; Reis ST; Timoszczuk LS; Viana NI; Piantino CB; Morais DR; Moura CM; Abe DK; Silva IA; Srougi M; Dall'Oglio MF; Leite KR J Urol; 2012 Nov; 188(5):1951-6. PubMed ID: 22999546 [TBL] [Abstract][Full Text] [Related]
5. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer. Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812 [TBL] [Abstract][Full Text] [Related]
6. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337 [TBL] [Abstract][Full Text] [Related]
7. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520 [TBL] [Abstract][Full Text] [Related]
8. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis]. Li J; Liang SH; Lu X Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563 [TBL] [Abstract][Full Text] [Related]
9. Expression profile of microrna-145 in urothelial bladder cancer. Dip N; Reis ST; Srougi M; Dall'Oglio MF; Leite KR Int Braz J Urol; 2013; 39(1):95-101; discussion 102. PubMed ID: 23489501 [TBL] [Abstract][Full Text] [Related]
10. [Detection, verification and significance of differentially expressed miRNAs in bladder urothelial carcinoma]. Xie P; Xu F; Cheng W; Gao JP; Zhang ZY; Ge JP; Wei ZF; Xu XF Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3391-4. PubMed ID: 21223810 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646 [TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096 [TBL] [Abstract][Full Text] [Related]
13. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1. Zhang C; Ma X; Du J; Yao Z; Shi T; Ai Q; Chen X; Zhang Z; Zhang X; Yao X BJU Int; 2016 Oct; 118(4):578-89. PubMed ID: 26775686 [TBL] [Abstract][Full Text] [Related]
15. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results. Elsamman E; Fukumori T; Ewis AA; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Takahashi M; Nishitani MA; Baba Y; Kanayama HO Urol Oncol; 2006; 24(2):109-15. PubMed ID: 16520272 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells. Husted S; Søkilde R; Rask L; Cirera S; Busk PK; Eriksen J; Litman T Mol Pharm; 2011 Dec; 8(6):2055-62. PubMed ID: 21899346 [TBL] [Abstract][Full Text] [Related]
17. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study. Wu J; Lu C; Diao N; Zhang S; Wang S; Wang F; Gao Y; Chen J; Shao L; Lu J; Zhang X; Weng X; Wang H; Zhang W; Huang Y Hum Immunol; 2012 Jan; 73(1):31-7. PubMed ID: 22037148 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Choong ML; Yang HH; McNiece I Exp Hematol; 2007 Apr; 35(4):551-64. PubMed ID: 17379065 [TBL] [Abstract][Full Text] [Related]
19. microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. Tao J; Lu Q; Wu D; Li P; Xu B; Qing W; Wang M; Zhang Z; Zhang W Oncol Rep; 2011 Jun; 25(6):1721-9. PubMed ID: 21468550 [TBL] [Abstract][Full Text] [Related]
20. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome. Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]